Literature DB >> 11788796

Membrane glycoproteins of Newcastle disease virus: nucleotide sequence of the hemagglutinin-neuraminidase cloned gene and structure/function relationship of predicted amino acid sequence.

A Sagrera1, C Cobaleda, J M González De Buitrago, A García-Sastre, E Villar.   

Abstract

The nucleotide sequence of the glycoprotein hemagglutinin-neuraminidase (HN) gene of the Newcastle disease virus (NDV) strain Clone-30 has been determined. The open reading frame of the HN gene contains 1731 nucleotides and encodes a protein of 577 amino acids. Three highly conserved patterns among all paramyxovirus HN glycoproteins, and one additional conserved species-specific region are present. The protein contains five potential N-glycosylation sites, all but one located in the C-terminal external domain. The secondary structure prediction shows that the C-terminal external domain is mostly arranged in beta-sheets, while alpha-helices are predominantly located in the N-terminal domain. The nucleotide sequence data of the HN gene reported in this paper has been deposited in the GenBank database, under accession number AF098289.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11788796     DOI: 10.1023/a:1013756813921

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  36 in total

1.  Localization of functional sites on the hemagglutinin-neuraminidase glycoprotein of Sendai virus by sequence analysis of antigenic and temperature-sensitive mutants.

Authors:  S D Thompson; A Portner
Journal:  Virology       Date:  1987-09       Impact factor: 3.616

2.  Effect of tunicamycin on the replication of Sendai virus.

Authors:  K Nakamura; M Homma; R W Compans
Journal:  Virology       Date:  1982-06       Impact factor: 3.616

3.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

4.  Enzymatic N-glycosylation of synthetic Asn--X--Thr containing peptides.

Authors:  C Ronin; S Bouchilloux; C Granier; J van Rietschoten
Journal:  FEBS Lett       Date:  1978-12-01       Impact factor: 4.124

5.  Determination of the disulfide bond arrangement of Newcastle disease virus hemagglutinin neuraminidase. Correlation with a beta-sheet propeller structural fold predicted for paramyxoviridae attachment proteins.

Authors:  J J Pitt; E Da Silva; J J Gorman
Journal:  J Biol Chem       Date:  2000-03-03       Impact factor: 5.157

6.  The role of the individual cysteine residues in the formation of the mature, antigenic HN protein of Newcastle disease virus.

Authors:  L W McGinnes; T G Morrison
Journal:  Virology       Date:  1994-05-01       Impact factor: 3.616

7.  Synthesis, stability, and cleavage of Newcastle disease virus glycoproteins in the absence of glycosylation.

Authors:  T G Morrison; D Simpson
Journal:  J Virol       Date:  1980-10       Impact factor: 5.103

8.  Reducing agent-sensitive dimerization of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus correlates with the presence of cysteine at residue 123.

Authors:  J P Sheehan; R M Iorio; R J Syddall; R L Glickman; M A Bratt
Journal:  Virology       Date:  1987-12       Impact factor: 3.616

9.  Modulation of the activities of HN protein of Newcastle disease virus by nonconserved cysteine residues.

Authors:  L W McGinnes; T G Morrison
Journal:  Virus Res       Date:  1994-12       Impact factor: 3.303

10.  Structural features unique to each of the three antigenic sites on the hemagglutinin-neuraminidase protein of Newcastle disease virus.

Authors:  B Gotoh; T Sakaguchi; K Nishikawa; N M Inocencio; M Hamaguchi; T Toyoda; Y Nagai
Journal:  Virology       Date:  1988-03       Impact factor: 3.616

View more
  1 in total

Review 1.  Role of sialic acid-containing molecules in paramyxovirus entry into the host cell: a minireview.

Authors:  Enrique Villar; Isabel Muñoz Barroso
Journal:  Glycoconj J       Date:  2006-02       Impact factor: 2.916

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.